| Background: | Immunosuppressant. Selectively blocks signaling that leads to p70 S6 kinase activation (IC50 = 50 pM). Inhibits lymphokine-induced cell proliferation at the G1 phase. Induce apoptosis in a murine B cell line. Rapamycin has been used in vivo studies by i.p., i.m., and i.v. Administrations. |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Product Type: | Protein |
| Shipping: | 4 |
| Size: | 50 mg |
| Status: | RUO |
| Storage: | -20 |
| Target: | Rapamycin |
Applications:
There are no references for Rapamycin at this time.